Clinical trial with severe ME/CFS cases just published

Finally, a clinical trial with severe ME/CFS patients was published yesterday in PLoS ONE.

It’s a Phase III, double-blind placebo-controlled randomized clinical trial of the TLR-3 Agonist Rintatolimod, also known as Ampligen, in 234 subjects.

The fact that it’s a Phase III means that it will be considered as a scientifically validated treatment option.

Positive findings and very exciting news!

To read the PLoS ONE article click here.

To read about journalist Kelvin Lord’s journey on Ampligen you can go to his blog The New Ampligen Diaries.

Advertisements
This entry was posted in Ampligen, Clinical Trial and tagged , , . Bookmark the permalink.

2 Responses to Clinical trial with severe ME/CFS cases just published

  1. Lynn Weiss says:

    What about the testing & findings in the Gut tissue. My tissue was tested and found positive for several of the viruses including coxsackie B-3, B-4 by Dr. John Chia. Also HVV6 positive. Your post was very informative for a bedridden person as myself. It’s greatly appreciated.

    • Fatima says:

      Yes, finally a clinical trial with people who are severely affected with this illness, and bedridden like yourself. Thanks for your comment Lynn.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s